Public statement on Ivabradine JensonR: Withdrawal of the marketing authorisation in the European Union
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Source
European Medicines Agency
Additional Information
medication.label.product_type
assessment-report
medication.label.permit_number
EMA/875585/2018
medication.label.permit_validity
First published: 2018-12-20T14:40:00Z
Documents
Related Medications
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
AI Voice
Listen to the article content live